Evidence map›Paper›PMID 41997955›Full record

ArticleNature communications2026

Perirhinal cortex gains control of hippocampal seizures via broad downstream circuits in male mouse models.

Zhisheng Li, Wangjialu Lu, Yuhao Sun, Jing Xi, Jialu Chen, Nanxi Lai, Yuying Shao, Fan Fei, Heming Cheng, Zhong Chen and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhisheng Li *Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0009-0001-3100-3939
Wangjialu Lu *Key Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Yuhao SunKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Jing XiKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Jialu ChenKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Nanxi LaiKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Yuying ShaoKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Fan FeiZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Heming ChengZhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Zhong ChenKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China. chenzhong@zju.edu.cn.ORCID http://orcid.org/0000-0003-4755-9357
Yi WangKey Laboratory of Medical Neurobiology of the Ministry of Health of China, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China. wang-yi@zju.edu.cn.ORCID http://orcid.org/0000-0002-1350-2961

Funding

National Natural Science Foundation of China (National Science Foundation of China) 2025ZD0219000 (Y.W.)National Natural Science Foundation of China (National Science Foundation of China) 82330116 (Z.C)National Natural Science Foundation of China (National Science Foundation of China) U23A20533 (Y.W.)Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LD22H310003 (Z.C)Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LD24H310001 (Y.W.)
6 · The paper itself

Abstract

The perirhinal cortex (PRh) has extensive interconnections with limbic structures, including the fasciola cinerea (FC), a recently identified node and therapeutic target in temporal lobe epilepsy. However, the neural circuit basis between PRh and FC in seizure progression remains unclear. Here we show that the PRh provides the principal excitatory input to the FC and plays an important role in seizure modulation in male mouse epilepsy models. PRh-FC projections are strongly activated during seizures, and their inhibition delays seizure progression. Moreover, PRh excitatory neurons bidirectionally regulate seizure development and engage multiple distinct downstream pathways, including projections to the FC, infralimbic cortex, and lateral entorhinal cortex. Notably, suppressing PRh activity produces more effective seizure attenuation than targeting individual projections. These findings identify the PRh as a critical hub that coordinates distributed circuits to control seizure progression, highlighting its potential as a therapeutic target for epilepsy treatment.

Indexed as

Epilepsy, Temporal LobeHippocampusPerirhinal CortexSeizuresAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLNeural PathwaysNeurons

Identifiers

PMID41997955
PMCPMC13276240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.